Event and Webinars

Explore Insights

Read more
AI-generated music on an abstract techno background. The concept of artificial intelligence in programming and the Internet.
Universal Music Group and Spotify Partner on AI: A Familiar Song with A New Tune

The announcement on May 21, 2026, that Universal Music Group (UMG) and Spotify are partnering on a new AI-powered music initiative is one of the latest advancements at the intersection of artificial intelligence and the music industry. And yet, something about it strongly echoes a past deal between the two, when they also joined forces…

Read more
Microsoft Power Apps websites focusing on Power Apps
Power Platform: When and Why to Use Canvas, Model-Driven, Power Pages and Code Apps 

When someone says, “just build it in Power Apps,” the next question should always be: which one?  Power Apps isn’t a single tool. It’s four different app types, each built for a different audience, a different data scale and a different level of technical skill. Picking the wrong app costs real time and money.   This guide helps you pick the right one before you start…

Read more
featured-image-4
CalCPA Names Withum Leaders to 2026 NorCal Top 50 Accountants

Top 50 Accountant Honorees at Withum Brandon Yip Brandon Yip is a partner who leads Withum’s Technology and Emerging Growth Services Team in the San Francisco Bay Area. He focuses on advising public and private companies on audit, regulatory and transactional matters while helping innovation-driven organizations scale. Deeply connected to Northern California, he supports the region’s technology and life sciences ecosystem…

Read more
Tax Planning Concept: Businessman Arranging Wooden Blocks with Financial Icons and TAX Text Representing Corporate Finance and Growth Strategy
Why Global Structuring and Transfer Pricing Matter for Life Sciences Companies 

The life sciences industry is characterized by high-value intellectual property (“IP”), extensive research and development (R&D), complex regulatory environments, and global supply chains. Life sciences companies are increasingly global from day one where R&D is performed in one country, clinical trials in others, IP held centrally, and manufacturing and commercialization is performed elsewhere. These unique attributes create opportunity, but it also creates tax risk if global structuring and transfer pricing are not…

Center-Parallax-768x490

Stay Ahead of the Curve

Add the latest insights to your equation, from accounting updates to advisory trends and tax developments that matter.

Subscribe Here